45
Participants
Start Date
June 30, 2017
Primary Completion Date
May 11, 2018
Study Completion Date
May 11, 2018
active neuromodulation for episodic migraine headache
Non-invasive brainstem neuromodulator. Active and placebo devices appear identical
placebo neuromodulation for episodic migraine headache
Sham non-invasive brainstem neuromodulator. Active and placebo devices appear identical
Jefferson Headache Center, Philadelphia
Neurology Research Institute, West Palm Beach
Cleveland Clinic, Cleveland
Michigan Headache Pain & Neurological Inst., Ann Arbor
Diamond Headache Clinic, Chicago
Study Metrix Research, City of Saint Peters
Mayo Clinic, Scottsdale
Dartmouth-Hitchcock Medical Center, Lebanon
King's College London, London
University of Kent, Canterbury
Lead Sponsor
Scion NeuroStim
INDUSTRY